Potential of non-coding RNA as biomarkers in heart failure

Médecine sciences : M/S
Florence Pinet, Christophe Bauters

Abstract

Heart failure is a major public health problem with an estimated prevalence of 1-2% in the adult population in developed countries. Despite some progress, the prognosis of heart failure is associated with high mortality. There is a need for prognostic markers for heart failure, such as circulating biomarkers, in order to better identify individual heart failure patients with high risk of early death, and to improve the selection of patients for invasive treatment with limited availability such as heart transplantation. Among the non coding RNA family, we investigated the potentiality of long non coding RNAs (lncRNA) as potential biomarkers in heart disease. We observed that the plasmatic levels of the lncRNA named LIPCAR may predict early mortality in patients with heart failure independently of the etiology and may improve clinical-decision making for a more personalized treatment of "high-risk" patients.

References

Oct 13, 1998·Journal of the American College of Cardiology·P de GrooteJ M Lablanche
Apr 30, 2005·Current Opinion in Cardiology·Douglas S Lee, Ramachandran S Vasan
Aug 30, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yu-Kwan Tong, Y M Dennis Lo
Oct 24, 2006·The American Journal of Cardiology·Christine SavoyeUNKNOWN REmodelage VEntriculaire study group
Aug 19, 2007·Heart·Arend Mosterd, Arno W Hoes
May 16, 2008·The New England Journal of Medicine·Eugene Braunwald
Jun 2, 2009·Médecine sciences : M/S·Yannick Ladeiro, Jessica Zucman-Rossi
Apr 10, 2012·The American Journal of Cardiology·Marie FertinChristophe Bauters
Jan 26, 2013·International Journal of Cardiology·Christophe BautersThomas Thum
Mar 7, 2013·Genetics·Johnny T Y KungJeannie T Lee
Jul 28, 2013·Circulation Research·Eugene Braunwald
Aug 31, 2013·Circulation Research·Véronique L Roger
Aug 31, 2013·Circulation Research·Regalla Kumarswamy, Thomas Thum
Oct 24, 2013·Médecine sciences : M/S·Angélique Gougelet, Sabine Colnot
Feb 22, 2014·Circulation Research·Kun WangPei-Feng Li
Mar 26, 2014·Circulation Research·Regalla KumarswamyThomas Thum
Apr 2, 2014·Médecine sciences : M/S·Sylvain BaulandeMathilde Duthieuw
May 9, 2014·Circulation Research·Gerald W Dorn
Jul 19, 2014·Circulation Research·Mélanie VausortYvan Devaux
Jul 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Scot J MatkovichGerald W Dorn
Sep 2, 2014·Médecine sciences : M/S·Eve-Lyne MathieuSalvatore Spicuglia
Sep 10, 2014·Nature Reviews. Cardiology·Thomas Thum
Nov 20, 2014·Médecine sciences : M/S·Simone Bateman
Dec 5, 2014·Genome Medicine·Mika GustafssonMikael Benson
Apr 10, 2015·Médecine sciences : M/S·Thierry Pedrazzini
Sep 6, 2015·Médecine sciences : M/S·Marc Billaud, Xavier Guchet

❮ Previous
Next ❯

Citations

Oct 11, 2017·Médecine sciences : M/S·Ferdinand Jagot, Nathalie Davoust
Mar 25, 2016·Médecine sciences : M/S·Zoheir HizirEmanuela Repetto
Nov 19, 2015·Médecine sciences : M/S·Jeanne Mialet-PerezAngelo Parini
Oct 21, 2015·Médecine sciences : M/S·Yannis Sainte-MarieFrank Lezoualc'h

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.